India · Delayed Price · Currency is INR Neuland Laboratories Statistics
Total Valuation
NSE:NEULANDLAB has a market cap or net worth of INR 169.89 billion. The enterprise value is 170.85 billion.
| Market Cap | 169.89B |
| Enterprise Value | 170.85B |
Important Dates
The last earnings date was Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 12.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 11.52% |
| Owned by Institutions (%) | 21.59% |
| Float | 7.18M |
Valuation Ratios
The trailing PE ratio is 94.84 and the forward PE ratio is 43.52.
| PE Ratio | 94.84 |
| Forward PE | 43.52 |
| PS Ratio | 10.79 |
| PB Ratio | 10.49 |
| P/TBV Ratio | 12.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 95.38 |
| EV / Sales | 10.85 |
| EV / EBITDA | 55.27 |
| EV / EBIT | 70.60 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.86 |
| Debt / FCF | n/a |
| Interest Coverage | 14.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.49% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 4.40% |
| Revenue Per Employee | 8.78M |
| Profits Per Employee | 998,504 |
| Employee Count | 1,794 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:NEULANDLAB has paid 616.50 million in taxes.
| Income Tax | 616.50M |
| Effective Tax Rate | 25.60% |
Stock Price Statistics
The stock price has increased by +16.24% in the last 52 weeks. The beta is 0.03, so NSE:NEULANDLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +16.24% |
| 50-Day Moving Average | 14,501.76 |
| 200-Day Moving Average | 14,219.44 |
| Relative Strength Index (RSI) | 44.70 |
| Average Volume (20 Days) | 46,805 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEULANDLAB had revenue of INR 15.75 billion and earned 1.79 billion in profits. Earnings per share was 139.62.
| Revenue | 15.75B |
| Gross Profit | 7.77B |
| Operating Income | 2.42B |
| Pretax Income | 2.41B |
| Net Income | 1.79B |
| EBITDA | 3.04B |
| EBIT | 2.42B |
| Earnings Per Share (EPS) | 139.62 |
Balance Sheet
The company has 1.69 billion in cash and 2.65 billion in debt, with a net cash position of -958.12 million.
| Cash & Cash Equivalents | 1.69B |
| Total Debt | 2.65B |
| Net Cash | -958.12M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 16.20B |
| Book Value Per Share | 1,262.78 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.33%, with operating and profit margins of 15.36% and 11.37%.
| Gross Margin | 49.33% |
| Operating Margin | 15.36% |
| Pretax Margin | 15.29% |
| Profit Margin | 11.37% |
| EBITDA Margin | 19.31% |
| EBIT Margin | 15.36% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 12.00 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -14.29% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 1.05% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |